The Cleveland Clinic data showed that 20% of people restarted their original medication within 12 months, and another 27% switched to a different medication
Clinicians should monitor patients for potential adverse effects including pancreatitis (severe, persistent abdominal pain), gallbladder disease (right upper quadrant pain), diabetic retinopathy complications (especially with rapid glucose improvement), acute kidney injury with dehydration, and hypoglycemia when combined with insulin or sulfonylureas
Balancing Brain Chemicals These medicines may also affect other brain chemicals like serotonin and GABA
SURMOUNT-5 Trial Investigators
LISTEN NOW Got a confidential tip
Black Box Warning According to FDA prescribing information, semaglutide products carry a boxed warning regarding thyroid C-cell tumors observed in rodent studies